Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers

@article{Zucchi2020NeurofilamentsIM,
  title={Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers},
  author={E. Zucchi and V. Bonetto and Gianni Sorar{\`u} and Ilaria Martinelli and Piero Parchi and R. Liguori and J. Mandrioli},
  journal={Molecular Neurodegeneration},
  year={2020},
  volume={15}
}
  • E. Zucchi, V. Bonetto, +4 authors J. Mandrioli
  • Published 2020
  • Medicine
  • Molecular Neurodegeneration
  • Motor neuron diseases (MNDs) are etiologically and biologically heterogeneous diseases. The pathobiology of motor neuron degeneration is still largely unknown, and no effective therapy is available. Heterogeneity and lack of specific disease biomarkers have been appointed as leading reasons for past clinical trial failure, and biomarker discovery is pivotal in today’s MND research agenda. In the last decade, neurofilaments (NFs) have emerged as promising biomarkers for the clinical assessment… CONTINUE READING

    Figures from this paper

    References

    SHOWING 1-10 OF 118 REFERENCES
    Neurofilament light chain as a biomarker in neurological disorders
    • 99
    • PDF
    Neurofilaments as biomarkers in neurological disorders
    • 322
    • PDF
    Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
    • 150
    Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
    • 51
    • PDF
    Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
    • 35
    • PDF
    Biomarkers in Motor Neuron Disease: A State of the Art Review
    • 21
    • PDF
    Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
    • 253
    • PDF
    Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
    • 7
    • Highly Influential